Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2018
Price : $35 *
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Carcinoma; Rectal cancer
- Focus Diagnostic use
- Acronyms RECT
- 08 Aug 2018 Status changed from not yet recruiting to recruiting.
- 11 Apr 2018 Planned initiation date changed from 1 Sep 2017 to 1 May 2018.
- 25 Jul 2017 Planned initiation date changed from 1 Apr 2017 to 1 Sep 2017.